Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-05

Clinical Trial Update: Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing carbetocin with oxytocin for prevention of postpartum hemorrhage in patients with severe preeclampsia; current trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Saint Thomas Hospital, Panama | Conditions: Severe Preeclampsia, Postpartum Hemorrhage | Phase 3 | Status: UNKNOWN